Stocks to Watch: The domestic stock market will likely open in the green on Wednesday, June 25. The GIFT NIFTY futures suggest that the NIFTY50 index will open 105 points higher.
Here is a list of stocks that may remain in focus today.
J.B. Chemicals & Pharmaceuticals: The company has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg, which is indicated for relief of symptoms of depression.
Aurobindo Pharma: In its filing to stock exchanges, CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing authorisation from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for Dyrupeg™, its pegylated filgrastim biosimilar version.
Earlier in April 2025, Dyrupeg™ received marketing authorisation in the European Union from the European Commission (EC). This is CuraTeQ’s third biosimilar to be approved by MHRA after the approval of Bevqolva™ in December 2024 and Zefylti™ in May 2025.
HDFC Bank: Shares will be in focus as arm HDB Financial Services will launch its IPO today. The NBFC aims to raise ₹12,500 crore from the public issue.
Timex Group India: Shares will be in focus as Timex Group Luxury Watches BV, the global watchmaker, will sell a 15% share in its Indian entity, Timex Group India, through an offer for sale (OFS). The OFS is scheduled to open for non-retail investors on Wednesday, June 25, and for retail investors on Thursday, June 26. The offer will be open on BSE and the National Stock Exchange, it added.
READ MORE
PTC Industries: Aerolloy Technologies Limited (ATL) and Safran Aircraft Engines announce the signature of a Memorandum of Understanding (MOU) to develop cooperation on the manufacturing of components and materials for military aircraft engines. ATL is a wholly owned subsidiary of PTC Industries Limited, specialised in the manufacturing of castings and materials for aerospace applications.
Safran Aircraft Engines is engaged, inter alia, in the design, development, production, and maintenance of civil and military engines.
Mastek: The company said that Raghavendra Jha, Chief Financial Officer and Key Managerial Personnel of the company, has submitted his resignation from the services of the company through email on June 23, 2025.
Bajel Projects: In its press release, the company said it has secured an order from a leading private player in the energy and power transmission sector. This order falls within the "Large" order band (valued between ₹100 crore and ₹200 crore), as per the company's internal classification.
RITES: The company has received the Letter of Intent from Gujarat Urban Development Company Limited for “Appointment of TPI agency for WSS/UGD/STP projects under Amrut 2.0/SJMMSVY under GUDC for ULBs of Gujarat”. The size of the order is ₹28.50 crore, exclusive of GST.
Glenmark Pharma: The pharma company has launched TEVIMBRA® (tislelizumab) in India following the approval by the Central Drugs Standard Control Organisation (CDSCO). TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines), a global oncology leader committed to delivering advanced treatments for cancer patients worldwide.
Hindalco: Aditya Birla Group's metals arm Hindalco Industries Ltd on Tuesday said it will acquire US-based AluChem Companies Inc. for $125 million (₹1,075 crore) in an all-cash deal.
The acquisition of AluChem Companies is a strategic move designed primarily to expand the company's global footprint for its downstream portfolio of speciality alumina and alumina products, according to a regulatory filing.
In a statement, the company said the acquisition will be carried out through Hindalco's step-down wholly owned arm, Aditya Holdings LLC.
.png)
